Camber Pharmaceuticals is pleased to announce the addition of Diclofenac Potassium for Oral Solution to its current portfolio.
PISCATAWAY, N.J. — Camber Pharmaceuticals is pleased to announce the addition of Diclofenac Potassium for Oral Solution to its current portfolio.
Diclofenac Potassium for Oral Solution is a non-steroidal anti-inflammatory drug (NSAID) indicated for the acute treatment of migraine attacks with or without aura, in adults 18 years of age or older.
Diclofenac Potassium for Oral Solution is available in 50 mg strength and supplied as a box of 9 individual packets.
The lawsuit brought by pension funds accused Cencora’s leadership of ignoring red flags around how the company was dispensing the highly addictive painkillers for years — including dubiously large opioid shipments — and failing to properly monitor opioid sales.
“Cencora is a purpose-led, purpose-driven company. We are united in our responsibility to create healthier futures,” Mauch explained.
“The landscape of pharmacy is changing rapidly, and it’s no secret these changes bring challenges,” said Tim Cernohous, senior vice president and president of community, retail and long-term-care pharmacy at Cencora.
Until today, Ozempic has not been available to eligible self-paying patients at this price.
Now in its fourth year, the contest is part of the grooming company's ongoing mission to recognize and reward those who embody their philosophy of making the world a better – or 'bearder' – place to live.
A lifestyle brand for women and children of color.
By Rachel Tetreault, general manager for omnichannel health care at Market Performance Group
The lawsuit brought by pension funds accused Cencora’s leadership of ignoring red flags around how the company was dispensing the highly addictive painkillers for years — including dubiously large opioid shipments — and failing to properly monitor opioid sales.
